Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease
Engelken, H.J.; Martin, M.
Die Medizinische Welt 25(25): 1122-1124
1974
ISSN/ISBN: 0025-8512 PMID: 4418430 Document Number: 82474
Document emailed within 1 workday
Related Documents
Sailer, S.; Pilger, E. 1985: Fibrinolytic therapy of peripheral arterial occlusive disease Wiener Medizinische Wochenschrift 135(15-16): 393-399Altmann, E.; Stelzner, C.; Graf, A. 1999: Fibrinolytic, revascularizing therapy of peripheral arterial occlusive disease Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(9): 651-658
Rieger, H. 1989: Conservative therapy of arterial occlusive disease Herz 14(1): 1-11
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315
Kandziora, J. 1973: Therapy of arterial occlusive disease of the lower limbs using Tebonin Zeitschrift für Allgemeinmedizin 49(14): 682-685
Von Ungern-Sternberg, A.; Schuster, C.J. 1975: New criteria for the objectivation of drug therapy in arterial occlusive disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 879-882
Creutzig, A. 1991: Therapy of peripheral arterial occlusive disease with special reference to prostaglandins Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 46(3): 59-67
Ernst, E. 1983: Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. a critical analysis Münchener Medizinische Wochenschrift 125(37): 796-798
Spittell, J.A. 1982: Diagnosis and treatment of occlusive peripheral arterial disease Geriatrics 37(1): 57-67
Baroi, L.G.; Iacob, L.; Popa, R.F. 2014: Surgical techniques in the treatment of multilevel arterial occlusive disease Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(4): 1034-1039
Martínez, R.; García Medina, V.; Ferral, H. 2001: Endovascular treatment of arterial occlusive disease of the iliac arteries Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 53(6): 543-551
Mathias, K. 1987: Catheter treatment of arterial occlusive disease of supraaortic vessels Der Radiologe 27(12): 547-554
Johnston, K.W.; Colapinto, R.F.; Harries-Jones, E.P.; DeMorais, D.; Kalman, P.G.; Baird, R.J.; Goldman, B.S.; Key, J.A.; Weisel, R.D. 1980: Transluminal dilatation in the treatment of peripheral arterial occlusive disease Canadian Journal of Surgery. Journal Canadien de Chirurgie 23(6): 547-548
Laufman, H. 1974: Empiric use of anticoagulant and fibrinolytic agents in surgical therapy American Surgeon 40(1): 15-21
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Criado, F.J. 1994: Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost? Journal des Maladies Vasculaires 19 Suppl A: 178-182
Baggio, D.; Madore, F.; Lalonde, G. 2000: Oral anticoagulant therapy for heart disease: results in actual cardiology practice Canadian Journal of Cardiology 16(2): 153-161
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Marshall, M. 1982: Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy Fortschritte der Medizin 100(14): 650-655